ASICs, including ASIC and ASIC3, have potential as targets for the treatment of migraine, and inhibitors such as amiloride, mambalgin-1, and APETx2 that showed a promising alleviating mechanical allodynia effect in animal models. The gene discussed is ASIC3; the disease is migraine disorder.